Charles Brenner, PhD, director of the Obesity Initiative at the University of Iowa, discusses properties of nicotinamide riboside that have been uncovered since its initial discovery in 2004.
Neal Barnard, MD, President of the Physicians Committee for Responsible Medicine, discusses evidence on the key role of plant-based eating patterns in the treatment of diabetes, as well as the importance of...
Kim Carmichael, MD, from the Washington University School of Medicine in St. Louis, discusses his column, “What Do You Need to Know About Diabetic Gastroparesis?”
In this podcast, Lucia Novak reflects on how the ACP's 2018 HbA1c guidelines have impacted the landscape of diabetes care over the past year, and discusses the importance of individualized treatment.
Lucia Novak, director of Riverside Diabetes Center, gives strategies that may help improve diabetes management and prevent clinical inertia on patient and practitioner levels.
Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies.
Lucia Novak, director of Riverside Diabetes Center in Maryland, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’...
With increasing application of AI to health care, there is often concern that AI will replace clinicians. However, there is opportunity to optimize this partnership to improve patient care.
